Ranizumab and bevacizumab for the treatment of diabetic macular oedema.
AETSA
Record ID 32018000433
Spanish
Original Title:
Ranibizumab y bevacizumab en el tratamiento del edema macular diabético
Authors' objectives:
To assess the comparative efficacy of intravitreal ranibizumab versus intravitreal bevacizumab in patients with diabetic macular oedema.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.aetsa.org/publicacion/ranibizumab-y-bevacizumab-en-el-tratamiento-del-edema-macular-diabetico/
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Spain
MeSH Terms
- Macular Edema
- Diabetic Retinopathy
- Antibodies, Monoclonal
- Ranibizumab
- Bevacizumab
- Cost-Benefit Analysis
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.